logo

Lowell Anthony, MD

Lowell Anthony, MD

Oncology Lexington, KY

Chief, Medical Oncology, Professor of Medicine, University of Kentucky College of Medicine, Markey Cancer Center

Office Address

Office Map
  • 800 Rose Street, CC454
    University of Kentucky Medical Center
    Lexington, KY 40536
    Phone: (859) 323-6522
    Fax: (859) 257-7715

Dr. Anthony's Clinical Specialties & Interests

  • Oncology: General Oncology
  • Clinical Interests: Neuroendocrine tumors; Somatostatin; Pancreatic Neoplasms; Neuroendocrine Tumors; Gastrointestinal Neoplasms; Neoplasms; Octreotide; Carcinoid Tumor; Indium Radioisotopes

Dr. Anthony's Faculty Appointments & Work History

  • Chief, Division of Medical OncologyUniversity of Kentucky College of Medicine
    Lexington, KY

Dr. Anthony's Education & Medical Training

  • Vanderbilt UniversityVanderbilt UniversityFellowship, Clinical Pharmacology
  • Vanderbilt UniversityVanderbilt UniversityFellowship, Medical Oncology
  • Vanderbilt UniversityVanderbilt UniversityResidency, Internal Medicine
  • Vanderbilt Univ Sch of MedVanderbilt University School of MedicineMedical School

Dr. Anthony's Certifications & Licensure

  • TN State Medical LicenseTN State Medical License1981 - 2014
  • KY State Medical LicenseKY State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Anthony's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Anthony's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Safety And Efficacy Of PTK787/ZK222584 In Patients With Neuroendocrine Cancer
    Safety And Efficacy Of PTK787/ZK222584 In Patients With Neuroendocrine CancerNational Center For Research Resources
    2006 - 2006
  • Study To Evaluate The Effect Of Age And Renal Function Of Octreoscan
    Study To Evaluate The Effect Of Age And Renal Function Of OctreoscanNational Center For Research Resources
    2005 - 2006
  • Clinical Trial With Thymitaq Administered To Patients
    Clinical Trial With Thymitaq Administered To PatientsNational Center For Research Resources
    2004 - 2004
  • Study Comparing Venofer Intravenously To NO Iron Tx
    Study Comparing Venofer Intravenously To NO Iron TxNational Center For Research Resources
    2004 - 2004
  • Study To Evaluate The Effect Of Age And Renal Function
    Study To Evaluate The Effect Of Age And Renal FunctionNational Center For Research Resources
    2004 - 2004
  • Iodine-131 Anti-B1 Antibody For NHL
    Iodine-131 Anti-B1 Antibody For NHLNational Center For Research Resources
    2000 - 2001
  • Therapeutic Indium 111 Pentetreotide In Somatostain Receptor Expressing Cancers
    Therapeutic Indium 111 Pentetreotide In Somatostain Receptor Expressing CancersNational Center For Research Resources
    1998 - 2001
  • Comparative, 2 Way Crossover Multiple Dose Of Iv/Oral Regimen Of Mesna
    Comparative, 2 Way Crossover Multiple Dose Of Iv/Oral Regimen Of MesnaNational Center For Research Resources
    1996 - 1997
  • Routes Of Ifosfamide Metabolism
    Routes Of Ifosfamide MetabolismNational Cancer Institute
    1996 - 1996
  • Vu Sando LAR 2 A Tolerability &Efficacy Of Multiple Doses Of Sandostatin
    Vu Sando LAR 2 A Tolerability &Efficacy Of Multiple Doses Of SandostatinNational Center For Research Resources
    1996 - 1997
  • Phase I Dosing Study Of Sandostatin LAR Given IM In Advanced Cancer
    Phase I Dosing Study Of Sandostatin LAR Given IM In Advanced CancerNational Center For Research Resources
    1995 - 1995
  • Phase I Study Of Somatuline In The Management Of Lung Cancer
    Phase I Study Of Somatuline In The Management Of Lung CancerNational Center For Research Resources
    1993 - 1997
  • Routes Of Ifosfamide Metabolism
    Routes Of Ifosfamide MetabolismNational Center For Research Resources
    1993 - 1993
  • Study Of Octreotide In The Management Of Neuroendocrine Tumors
    Study Of Octreotide In The Management Of Neuroendocrine TumorsNational Center For Research Resources
    1992 - 1997
  • Routes Of Ifosfamide Metabolism
    Routes Of Ifosfamide MetabolismNational Cancer Institute
    1992 - 1995
  • Multiple Dose Urinary And Serum Pharmacokinetics Of Mesna And Dimesna
    Multiple Dose Urinary And Serum Pharmacokinetics Of Mesna And DimesnaNational Center For Research Resources
    1992 - 1993
  • Phase I Study Of Octreotide In The Management Of Neuroendocrine Tumors
    Phase I Study Of Octreotide In The Management Of Neuroendocrine TumorsNational Center For Research Resources
    1991 - 1991
  • Pharmacogenetic Aspects Of Cyclophosphamide Metabolism
    Pharmacogenetic Aspects Of Cyclophosphamide MetabolismNational Center For Research Resources
    1988 - 1990

Dr. Anthony's Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Sagamore Health Plus
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Anthony's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV